Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging

ObjectiveThis study aimed to assess the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) combined with lenvatinib and immunotherapy and explore its potential as a conversion treatment for unresectable hepatocellular carcinoma (uHCC).MethodsA retrospective analysis was performed o...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Weihao Zhang, Xiaohui Zhao, Wei Gao, Tongguo Si, Qiang Zou, Xueling Yang, Wenge Xing, Haipeng Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Subjects:	unresectable hepatocellular carcinoma hepatic arterial infusion chemotherapy lenvatinib immunotherapy conversion
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1596864/full